Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × elacestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Sarcoma, Endometrial Stromal 1 Recurrence 1 Perivascular Epithelioid Cell Neoplasms 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1 ER+ Breast Cancer 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Patients 1 Advanced Breast Cancer 1 Adenosarcoma of the uterus 1

Interventions

Radiosurgery 79 Capecitabine 77 Oxaliplatin 74 Fluorouracil 69 Bevacizumab 69 Gemcitabine 67 Leucovorin 61 pembrolizumab 53 Nivolumab 52 Paclitaxel 48 Irinotecan 47 Radiotherapy 45 Cisplatin 44 Everolimus 38 Drug Therapy 36 Docetaxel 36 Magnetic Resonance Spectroscopy 35 Cyclophosphamide 35 Cetuximab 35 Ipilimumab 32 Carboplatin 32 Trastuzumab 31 Sunitinib 30 Sorafenib 26 Erlotinib Hydrochloride 25 Doxorubicin 23 Surveys and Questionnaires 20 Surgical Procedures, Operative 20 Biopsy 19 Temozolomide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06201234 2025-12-01

ELEMENT

GBG Forschungs GmbH

Phase 2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡